NeuPath Health Inc (NPTH) — Capital Reinvestment Ratio
Latest as of December 2025:
0.37x
NeuPath Health Inc (NPTH) has a Capital Reinvestment Ratio of 0.37x as of December 2025, meaning it reinvests 0% of its operating cash flow (CA$662.00K) in capital expenditures (CA$245.00K). See NeuPath Health Inc (NPTH) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.37x
Capex / Operating Cash Flow
Operating Cash Flow
CA$662.00K
CAD
Capital Expenditures
CA$245.00K
CAD
Data as of
Dec 2025
Most recent filing
NeuPath Health Inc Capital Reinvestment Ratio (2021–2025)
This chart tracks NeuPath Health Inc's Capital Reinvestment Ratio across 5 annual periods.
Annual Capital Reinvestment Ratio for NeuPath Health Inc (2021–2025)
Year-by-year Capital Reinvestment Ratio for NeuPath Health Inc from 2021 to 2025. For live market cap and broader valuation context, see NPTH stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CAD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.22x | CA$4.00 Million | CA$863.00K | ▼ -40.7% |
| 2024 | 0.36x | CA$2.61 Million | CA$948.00K | ▲ +212.1% |
| 2023 | 0.12x | CA$3.03 Million | CA$353.00K | ▼ -93.0% |
| 2022 | 1.67x | CA$738.00K | CA$1.23 Million | ▲ +679.4% |
| 2021 | 0.21x | CA$1.92 Million | CA$411.00K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow